Something is moving in European drug research for children, but a more focused effort concerning all therapeutic needs is necessary

There is a well-recognised lack of suitable paediatric therapies. This is caused by the great difficulty in performing paediatric clinical trials. However, a recent assessment1 evaluating and comparing ongoing and published paediatric drug-therapy trials found that significant therapeutic research efforts are ongoing. The analysis examined data from both clinical trials in the Drug Evaluation in Children (DEC-net) European register of paediatric drug therapy trials2 and published articles, and compared the results with the WHO European Region Top 7 Burden of Disease data …